Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0A1FB
|
|||
| Former ID |
DIB016964
|
|||
| Drug Name |
RPA gene based adenovirus 4 vector vaccine
|
|||
| Synonyms |
Anthrax vaccine (oral/capsule), PaxVax; RPA gene based adenovirus 4 vector vaccine (oral, capsule, anthrax); RPA gene based adenovirus 4 vector vaccine (oral, capsule, anthrax), PaxVax
Click to Show/Hide
|
|||
| Indication | Anthrax [ICD-11: 1B97; ICD-9: 22] | Phase 1 | [1] | |
| Company |
PharmAthene
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Safety and immunogenicity of an oral, replicating adenovirus serotype 4 vector vaccine for H5N1 influenza: a randomised, double-blind, placebo-controlled, phase 1 study. Lancet Infect Dis. 2013 Mar;13(3):238-50. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.